Literature DB >> 23925884

Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α.

Deborah D Crane1, Robin Ireland, Joshua B Alinger, Pamela Small, Catharine M Bosio.   

Abstract

Francisella tularensis is a Gram-negative facultative intracellular pathogen that causes an acute lethal respiratory disease in humans. The heightened virulence of the pathogen is linked to its unique ability to inhibit Toll-like receptor (TLR)-mediated inflammatory responses. The bacterial component and mechanism of this inhibition are unknown. Here we show that lipids isolated from virulent but not attenuated strains of F. tularensis are not detected by host cells, inhibit production of proinflammatory cytokines by primary macrophages in response to known TLR ligands, and suppress neutrophil recruitment in vivo. We further show that lipid-mediated inhibition of inflammation is dependent on TLR2, MyD88, and the nuclear hormone and fatty acid receptor peroxisome proliferator-activated receptor α (PPARα). Pathogen lipid-mediated interference with inflammatory responses through the engagement of TLR2 and PPARα represents a novel manipulation of host signaling pathways consistent with the ability of highly virulent F. tularensis to efficiently evade host immune responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925884      PMCID: PMC3807199          DOI: 10.1128/CVI.00319-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  45 in total

1.  Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.

Authors:  C M Bosio; K L Elkins
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.

Authors:  P Delerive; K De Bosscher; S Besnard; W Vanden Berghe; J M Peters; F J Gonzalez; J C Fruchart; A Tedgui; G Haegeman; B Staels
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  Trafficking and release of mycobacterial lipids from infected macrophages.

Authors:  W L Beatty; E R Rhoades; H J Ullrich; D Chatterjee; J E Heuser; D G Russell
Journal:  Traffic       Date:  2000-03       Impact factor: 6.215

Review 4.  Endotoxins and disease mechanisms.

Authors:  D C Morrison; J L Ryan
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

5.  PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.

Authors:  A Chawla; Y Barak; L Nagy; D Liao; P Tontonoz; R M Evans
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.

Authors:  Robin Ireland; Rong Wang; Joshua B Alinger; Pamela Small; Catharine M Bosio
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

7.  Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids.

Authors:  Joo Y Lee; Anthony Plakidas; Won H Lee; Anne Heikkinen; Prithiva Chanmugam; George Bray; Daniel H Hwang
Journal:  J Lipid Res       Date:  2002-12-01       Impact factor: 5.922

8.  Correlation of bacteria lipid composition with antibiotic resistance.

Authors:  J K Dunnick; W M O'Leary
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

9.  Thermorecovery of cyanobacterial fatty acids at elevated temperatures.

Authors:  Xinyao Liu; Roy Curtiss
Journal:  J Biotechnol       Date:  2012-08-31       Impact factor: 3.307

10.  Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans.

Authors:  Valerie J Quesniaux; Delphine M Nicolle; David Torres; Laurent Kremer; Yann Guérardel; Jérôme Nigou; Germain Puzo; François Erard; Bernhard Ryffel
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  21 in total

1.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

2.  Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Authors:  Katharina Richard; Barbara J Mann; Aiping Qin; Eileen M Barry; Robert K Ernst; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

3.  Interferon Gamma Reprograms Host Mitochondrial Metabolism through Inhibition of Complex II To Control Intracellular Bacterial Replication.

Authors:  Forrest Jessop; Robert Buntyn; Benjamin Schwarz; Tara Wehrly; Dana Scott; Catharine M Bosio
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

4.  Virulent Francisella tularensis destabilize host mRNA to rapidly suppress inflammation.

Authors:  Timothy J Bauler; Jennifer C Chase; Tara D Wehrly; Catharine M Bosio
Journal:  J Innate Immun       Date:  2014-05-27       Impact factor: 7.349

5.  Temporal Requirement for Pulmonary Resident and Circulating T Cells during Virulent Francisella tularensis Infection.

Authors:  Lydia M Roberts; Tara D Wehrly; Robin M Ireland; Deborah D Crane; Dana P Scott; Catharine M Bosio
Journal:  J Immunol       Date:  2018-07-06       Impact factor: 5.422

6.  Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.

Authors:  Amanda J Griffin; Deborah D Crane; Tara D Wehrly; Catharine M Bosio
Journal:  Clin Vaccine Immunol       Date:  2014-11-19

7.  Rickettsia conorii survival in THP-1 macrophages involves host lipid droplet alterations and active rickettsial protein production.

Authors:  Paige E Allen; Robert C Noland; Juan J Martinez
Journal:  Cell Microbiol       Date:  2021-09-13       Impact factor: 3.715

8.  FTT0831c/FTL_0325 contributes to Francisella tularensis cell division, maintenance of cell shape, and structural integrity.

Authors:  Gregory T Robertson; Elizabeth Di Russo Case; Nicole Dobbs; Christine Ingle; Murat Balaban; Jean Celli; Michael V Norgard
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  Inclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent Francisella tularensis.

Authors:  Lydia M Roberts; Deborah D Crane; Tara D Wehrly; Joshua R Fletcher; Bradley D Jones; Catharine M Bosio
Journal:  J Immunol       Date:  2016-08-19       Impact factor: 5.422

10.  Metabolic Reprogramming of Host Cells by Virulent Francisella tularensis for Optimal Replication and Modulation of Inflammation.

Authors:  Elliott V Wyatt; Karina Diaz; Amanda J Griffin; Jed A Rasmussen; Deborah D Crane; Bradley D Jones; Catharine M Bosio
Journal:  J Immunol       Date:  2016-03-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.